CDNF and Parkinson disease: In summary, regardless of the fact that a single AAV8-AADC administration was unable to increase the dopamine level in the brain of severely lesioned PD rats due to low levodopa production from the few functional dopaminergic neurons, it could enhance the dopamine synthesis when combined with AAV8-CDNF administration.